Dynamic Biosystems

Dynamic Biosystems is a biotechnology high-tech enterprise supported by "full-chain single-cell multi-omics technology," integrating R&D, production, sales, and services. The company has established R&D and production bases in Xiamen, Suzhou, and Shanghai. Relying on several self-innovated, internationally leading technology platforms—such as "single-cell enrichment and detection," "single-cell sequencing," and "single-cell bioinformatics analysis"—the company focuses on exploring the enormous potential in precision oncology, reproductive health, and drug discovery, contributing to life sciences and clinical medicine with Chinese wisdom for the benefit of human health! The company has developed application kits for circulating tumor cell (CTC) detection and circulating fetal cell (CFC) detection, which are being progressively registered and approved for medical device licenses. Based on three proprietary single-cell sequencing technology platforms (Paired-seq, Digital-seq, and Well-paired-seq) and the ENCORE bioinformatics analysis algorithm, the company meets the needs of trace, large-scale, and ultra-high-throughput samples across different application scenarios, enabling single-cell multi-omics analysis (transcriptome, genome, metabolome, spatiotemporal transcriptome, etc.). Dynamic Biosystems actively collaborates with research institutes, medical institutions, and industry partners in related fields to explore potential applications of single-cell technologies and accumulate large-scale clinical research data. This accelerates the translation of single-cell technologies from scientific research to clinical and biopharmaceutical industry applications, transforming China's technological advantages in the single-cell era of precision medicine into medical advantages as early as possible, ultimately benefiting human health!